San Francisco, CA, United States of America

Lin Pan

This inventor holds 3 USPTO granted patents. Top assignee: Genentech, Inc.. Active years: 2021-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lin Pan. Retrieved from https://idiyas.com/inventor/lin-pan-p6vifvl7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lin Pan: Innovator in Anti-Fibrotic Therapy

Introduction

Lin Pan is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of medical therapies, particularly in the treatment of fibrotic disorders. With a total of 3 patents, his work is paving the way for advancements in healthcare.

Latest Patents

Lin Pan's latest patents focus on innovative methods of administering anti-fibrotic therapy. The present disclosure relates to methods of administering Compound I for treating fibrotic disorders, inflammatory disorders, or autoimmune disorders. This groundbreaking approach aims to improve patient outcomes and enhance the effectiveness of treatments.

Career Highlights

Lin Pan is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry, furthering his research and development efforts.

Collaborations

Some of Lin Pan's coworkers include Dorothy Sze-Wing Cheung and Jeffrey Mark Harris. Their collaboration fosters a dynamic environment for innovation and research, contributing to the success of their projects.

Conclusion

Lin Pan's contributions to anti-fibrotic therapy exemplify the impact of innovative thinking in medicine. His patents and work at Genentech highlight the importance of collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…